If they missed presenting half year results shouldn't they go into a trading halt? Or will the ASX just give them a slap on the wrist and tell them not to be tardy in future?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%